Zamenix P
Roen Surgical, Inc. · Decision date Aug 7, 2026
What did the FDA decide?
FDA records K253505 as a 510(k) premarket notification, with a decision dated Aug 7, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Aug 7, 2026
Regulatory record facts
- Identifier
- K253505
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Roen Surgical, Inc.
- Product code
- FGB
- Decision code
- SESE
- Decision date
- Aug 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ureteroscope And Accessories, Flexible/Rigid.
- Applicant
- Roen Surgical, Inc.
- Product code
- FGB
- FDA device class
- 2
FDA decision timeline
K253505 received
Application receipt date recorded by FDA.
K253505 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FGB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zhejiang Geyi Medical Instrument Co., Ltd. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Vein 360 | 510(k) clearance | Oct 20, 2026 | FDA | |
CVAC Aspiration SystemK261447 | Calyxo, Inc. | 510(k) clearance | Sep 15, 2026 | FDA |
| Guangzhou Red Pine Medical Instrument Co., Ltd. | 510(k) clearance | Sep 9, 2026 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | 510(k) clearance | Aug 26, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Roen Surgical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Daejeon
Sources and methodology
- Original FDA record: K253505
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

